$300 | Single User
$600 | Site License
$900 | Enterprise License

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review
[Published by Global Data]

Published by Global Data: 09 Aug 2016 | 14669 | In Stock
Related Topics: GlaxoSmithKline

Introduction

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlaxoSmithKline Pharmaceuticals Limited (GSK India) is a pharmaceutical company that manufactures and markets prescription medicines and vaccines. The prescription medicines range across therapeutic areas such as, analgesic, anti-infective, anti-inflammatory, anti parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, central nervous system (CNS) and oncology. The company offers a range of vaccines for the prevention of hepatitis A, hepatitis B, influenzae, diphtheria, tetanus, pertussis, rotavirus, tetanus toxoid, reduced diphtheria toxoid, human papillomavirus vaccine and others. The company is a subsidiary of GlaxoSmithKline Plc, which has operations across pharmaceuticals, vaccines and consumer health domains. GSK India is headquartered in Mumbai, Maharashtra, India.

GlaxoSmithKline Pharmaceuticals Limited Key Recent Developments

Jul 28, 2016: GlaxoSmithKline Pharmaceuticals delivers Q1 performance of 8% Sales growth

Mar 04, 2016: WNS Extends Contract with GSK to Provide High-end Analytical Services

Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration

Jan 12, 2016: Kuehne + Nagel and GlaxoSmithKline sign long term global logistics partnership contract

Sep 08, 2015: GSK Initiates Work On Pharmaceutical Facility In Karnataka, India

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    Section 1 - About the Company 6

    GlaxoSmithKline Pharmaceuticals Limited - Key Facts 6

    GlaxoSmithKline Pharmaceuticals Limited - Key Employees 7

    GlaxoSmithKline Pharmaceuticals Limited - Key Employee Biographies 8

    GlaxoSmithKline Pharmaceuticals Limited - Major Products and Services 9

    GlaxoSmithKline Pharmaceuticals Limited - History 14

    GlaxoSmithKline Pharmaceuticals Limited - Locations And Subsidiaries 17

    Head Office 17

    Other Locations & Subsidiaries 17

    Joint Venture 17

    Section 2 – Company Analysis 18

    GlaxoSmithKline Pharmaceuticals Limited - Business Description 18

    GlaxoSmithKline Pharmaceuticals Limited - Corporate Strategy 19

    GlaxoSmithKline Pharmaceuticals Limited - SWOT Analysis 20

    SWOT Analysis - Overview 20

    GlaxoSmithKline Pharmaceuticals Limited - Strengths 20

    Strength - Parent Synergy 20

    Strength - Focused Research Activities 20

    Strength - Strong Market Position 20

    GlaxoSmithKline Pharmaceuticals Limited - Weaknesses 21

    Weakness - Anti-Competitive Practices 21

    Weakness - Declined Sales 21

    GlaxoSmithKline Pharmaceuticals Limited - Opportunities 22

    Opportunity - Strategic Initiatives 22

    Opportunity - Changing Demographics 22

    Opportunity - Facility Expansions 22

    GlaxoSmithKline Pharmaceuticals Limited - Threats 23

    Threat - Government Regulations 23

    Threat - Uncertain R&D Outcomes 23

    Threat - Competitive Landscape 23

    GlaxoSmithKline Pharmaceuticals Limited - Key Competitors 24

    Section 3 – Company Financial Ratios 25

    Financial Ratios - Capital Market Ratios 25

    Financial Ratios - Annual Ratios 26

    Performance Chart 28

    Financial Performance 28

    Financial Ratios - Ratio Charts 29

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 30

    GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

    GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 31

    GlaxoSmithKline Pharmaceuticals Limited, Recent Deals Summary 32

    Section 5 – Company’s Recent Developments 33

    Jul 28, 2016: GlaxoSmithKline Pharmaceuticals delivers Q1 performance of 8% Sales growth 33

    Mar 04, 2016: WNS Extends Contract with GSK to Provide High-end Analytical Services 34

    Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration 35

    Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration 36

    Jan 12, 2016: Kuehne + Nagel and GlaxoSmithKline sign long term global logistics partnership contract 37

    Sep 08, 2015: GSK Initiates Work On Pharmaceutical Facility In Karnataka, India 38

    Aug 02, 2015: GSK India’s Greenfield Manufacturing Facility At Bengaluru To Begin Operations In 2017 39

    Jun 22, 2015: GlaxoSmithKline Pharmaceuticals appoints Annaswamy Vaidheesh as MD 40

    Jun 08, 2015: GSK Considering All Options Against CCI Order 41

    Feb 12, 2015: GlaxoSmithKline Pharmaceuticals announces Q4 Results 42

    Section 6 – Appendix 43

    Methodology 43

    Ratio Definitions 43

    About GlobalData 47

    Contact Us 47

    Disclaimer 47

List Of Tables
in GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Tables

GlaxoSmithKline Pharmaceuticals Limited, Key Facts 6

GlaxoSmithKline Pharmaceuticals Limited, Key Employees 7

GlaxoSmithKline Pharmaceuticals Limited, Key Employee Biographies 8

GlaxoSmithKline Pharmaceuticals Limited, Major Products and Services 9

GlaxoSmithKline Pharmaceuticals Limited, History 14

GlaxoSmithKline Pharmaceuticals Limited, Joint Venture 17

GlaxoSmithKline Pharmaceuticals Limited, Key Competitors 24

GlaxoSmithKline Pharmaceuticals Limited, Ratios based on current share price 25

GlaxoSmithKline Pharmaceuticals Limited, Annual Ratios 26

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 31

GlaxoSmithKline Pharmaceuticals Limited, Recent Deals Summary 32

Currency Codes 43

Capital Market Ratios 43

Equity Ratios 44

Profitability Ratios 44

Cost Ratios 45

Liquidity Ratios 45

Leverage Ratios 46

Efficiency Ratios 46

List Of Figures, Charts and Diagrams
in GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Figures

GlaxoSmithKline Pharmaceuticals Limited, Performance Chart (2012 - 2016) 28

GlaxoSmithKline Pharmaceuticals Limited, Ratio Charts 29

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 31

Additional Details

Publisher

Global Data

Publisher Information

Reference

14669 | GDPH113643FSA

Number of Pages

47

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
GlaxoSmithKline Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
GlaxoSmithKline K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline K.K. (GSK Japan) a subsidiary of GlaxoSmithKline Plc is a pharmaceutical comp...
10 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline Pharmaceuticals Limited (GSK India) is a pharmaceutical company that manufact...
04 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Plc (GSK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufact...
04 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile
SummaryGlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufact...
24 Feb 2016 by Global Data USD $250 More Info
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
SummaryGlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline Consumer Nigeria) a subsidiary of Glaxo...
09 Jan 2016 by Global Data USD $300 More Info
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
SummaryGlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline Consumer Nigeria) a subsidiary of Glaxo...
08 Nov 2015 by Global Data USD $300 More Info
Physician Views: Is GlaxoSmithKline's BRAF/MEK combo making headway in V600 mutation-positive melanoma patients?
Scope Although the clinical promise of cancer immunotherapies looks poised to see these products gai...
22 Jul 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Assessing the launch of GlaxoSmithKline's Breo Ellipta
Scope It remains early in the launch, but available evidence suggests that GlaxoSmithKline's Breo El...
21 Jan 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Can GlaxoSmithKline strike early with Anoro? / What role will dosing, inhaler type play in uptake of LAMA/LABA combinations for COPD?
ScopeThis year looks set to be one of notable evolution for the US chronic obstructive pulmonary dis...
01 Aug 2013 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)